What does a Patient Health Questionnaire‑9 (PHQ‑9) score of 8 indicate?

PHQ-9 Score of 8: Moderate Depressive Symptoms

A PHQ-9 score of 8 indicates moderate or subthreshold depressive symptoms with mild-to-moderate functional impairment, warranting consultation with psychology or psychiatry for diagnostic determination. 1, 2, 3

Score Classification and Clinical Significance

• A score of 8 falls within the moderate symptomatology range (8-14) on the PHQ-9 scale 1, 2, 3
• This cutoff of 8 is specifically recommended for cancer patients and similar populations, rather than the traditional cutoff of 10 used in general populations 1, 3
• The lower cutoff of 8 is supported by validation studies in cancer outpatients and meta-analyses demonstrating improved diagnostic accuracy in these populations 1, 4

Clinical Characteristics at This Score Level

Patients scoring 8 typically present with:

• Most depressive symptoms present but not necessarily meeting full criteria for major depressive disorder 1, 2
• Functional impairment ranging from mild to moderate in daily activities 1, 2, 3
• Subthreshold depressive symptoms that may still significantly impact quality of life 1, 3

Recommended Clinical Actions

Immediate steps:

• Seek consultation with psychology or psychiatry for formal diagnostic determination 1, 2, 3
• Identify pertinent history and specific risk factors including prior mood disorders, comorbid anxiety, substance use, chronic medical illnesses, disease recurrence/progression, social isolation, unemployment, and lower education level 2
• Assess for adequate coping skills and access to social/financial resources 2

Treatment considerations:

• First address medical causes of depressive symptoms such as uncontrolled pain, fatigue, infection-related delirium, or electrolyte disturbances before initiating depression-specific treatment 1, 3
• Consider low-intensity interventions including structured psychosocial group therapy led by licensed mental health professionals, individual psychological therapy using cognitive-behavioral approaches, or behavioral activation strategies 2
• Monitor for symptom progression or worsening that would necessitate escalation of care 2, 3

Important Caveats

Suicidality assessment:

• Always evaluate Item 9 (thoughts of self-harm), regardless of total score 1, 3
• Any endorsement of suicidal ideation requires immediate assessment of frequency and specificity 2, 3
• If risk of self-harm is identified, emergency mental health referral, safe environment provision, and one-to-one observation are mandatory 1, 2, 3

Cutoff score considerations:

• The traditional cutoff of 10 may miss clinically significant depression in cancer patients and other medically ill populations 1, 3
• Meta-analyses support cutoff scores between 8-11 as having acceptable diagnostic properties, with no substantial differences in sensitivity and specificity across this range 4
• Some validation studies in diverse settings have found optimal cutoffs as low as 7, particularly in primary care and hospital populations 5, 6

Follow-Up Timing

Repeat screening should occur at:

• Regular intervals during ongoing treatment 1, 2
• 3,6, and 12 months after treatment completion 2
• Disease recurrence or progression 2
• Personal transitions or family crises 2